South Korea vs Mus: Hypertension effective treatment coverage (controlled) … 30-79
South Korea
52.6%
in 2019
Mus
34.5%
in 2019
South Korea rank
2nd
Mus rank
1st
Hypertension effective treatment coverage (controlled) … 30-79 over time
- South Korea
- Mus
How they compare
South Korea currently reports 52.6% against 34.5% in Mus, a difference of 18.1%.
That makes South Korea's figure about 1.5 times Mus's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Mus ahead.
South Korea ranks 2nd and Mus ranks 1st of 193 countries.
Across the 3 decades both report, South Korea averaged higher in 2 and Mus in 1.
Head to head by decade
| Decade | South Korea | Mus | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.8% | 7.8% | 0.0% | Mus |
| 2000s | 25.7% | 11.9% | 13.8% | South Korea |
| 2010s | 47.0% | 25.2% | 21.8% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), South Korea or Mus?
- South Korea, at 52.6% against 34.5% in Mus as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between South Korea and Mus?
- 18.1%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Mus?
- 30 years are reported by both, from 1990 to 2019.
- How do South Korea and Mus rank globally for hypertension effective treatment coverage (controlled hypertension)?
- South Korea ranks 2nd and Mus ranks 1st of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.